Rockwell Medical Stock (NASDAQ:RMTI)
Previous Close
$2.33
52W Range
$1.16 - $5.15
50D Avg
$3.60
200D Avg
$2.30
Market Cap
$71.10M
Avg Vol (3M)
$774.80K
Beta
1.50
Div Yield
-
RMTI Company Profile
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
RMTI Performance
Peer Comparison
Ticker | Company |
---|---|
ITCI | Intra-Cellular Therapies, Inc. |
BFRI | Biofrontera Inc. |
EVOK | Evoke Pharma, Inc. |
ACOR | Acorda Therapeutics, Inc. |
ANIP | ANI Pharmaceuticals, Inc. |
AQST | Aquestive Therapeutics, Inc. |
LFCR | Lifecore Biomedical, Inc. |
PAHC | Phibro Animal Health Corporation |
GHSI | Guardion Health Sciences, Inc. |
RGC | Regencell Bioscience Holdings Limited |
IXHL | Incannex Healthcare Limited |
SSIC | Silver Spike Investment Corp. |
ACRX | Talphera, Inc. |
HUGE | FSD Pharma Inc. |
CPIX | Cumberland Pharmaceuticals Inc. |
PROC | Procaps Group S.A. |
ADMP | Adamis Pharmaceuticals Corporation |
LSDI | Lucy Scientific Discovery Inc. |
AGRX | Agile Therapeutics, Inc. |
KMDA | Kamada Ltd. |
COLL | Collegium Pharmaceutical, Inc. |
SXTC | China SXT Pharmaceuticals, Inc. |
EGRX | Eagle Pharmaceuticals, Inc. |